Vaccine clinical trial spotlight on Southeast Asia as “unique” opportunity beckons

Southeast Asia offers a unique opportunity for sponsors conducting clinical trials with vaccine candidates including faster recruitment, lower costs, and more favourable immunisation rates, according to Chris Chong, the clinical services senior director of the clinical research organisation (CRO) Novotech.